EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report) fell 0.3% during trading on Thursday . The company traded as low as $0.10 and last traded at $0.15. 605 shares changed hands during trading, a decline of 94% from the average session volume of 9,457 shares. The stock had previously closed at $0.16.
EOM Pharmaceuticals Price Performance
The firm’s 50-day moving average is $0.15 and its two-hundred day moving average is $0.15.
About EOM Pharmaceuticals
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.
See Also
- Five stocks we like better than EOM Pharmaceuticals
- With Risk Tolerance, One Size Does Not Fit All
- MarketBeat Week in Review – 03/24 – 03/28
- Most active stocks: Dollar volume vs share volume
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Top Stocks Investing in 5G Technology
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
